Randomized Phase 2 Trial to Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens Versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
Antimicrobial Agents and Chemotherapy- United States
doi 10.1128/aac.01232-12
Full Text
Abstract
Available in
Date
January 28, 2013
Authors
Publisher
American Society for Microbiology